Phase II clinical trials are an essential stage in drug development, where the safety and efficacy of a new treatment are evaluated in a relatively small number of patients. These trials aim to further assess the drug's safety profile, determine optimal dosing, and gather preliminary evidence of its effectiveness against the targeted condition. Phase II trials provide critical data to inform the design of larger Phase III trials and support decisions regarding the drug's advancement in the development process.